本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Allogene Therapeutics Inc.

1.78
+0.02001.14%
盤後1.77-0.0090-0.51%19:52 EDT
成交量:389.44萬
成交額:693.72萬
市值:6.14億
市盈率:-2.73
高:1.81
開:1.80
低:1.75
收:1.76
52周最高:4.46
52周最低:1.04
股本:3.45億
流通股本:2.62億
量比:0.67
換手率:1.49%
股息:- -
股息率:- -
每股收益(TTM):-0.6510
每股收益(LYR):-0.8652
淨資產收益率:-42.39%
總資產收益率:-22.08%
市淨率:1.41
市盈率(LYR):-2.06

資料載入中...

2026/09/02

重要事件披露

Form 8-K - Current report
2026/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/12

重要事件披露

Form 8-K - Current report
2026/08/07

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/22

重要事件披露

Form 8-K - Current report
2026/05/28

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/04/23

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/15

重要事件披露

Form 8-K - Current report
2026/04/13

重要事件披露

Form 8-K - Current report
2026/04/13

重要事件披露

Form 8-K - Current report